Literature DB >> 18799722

CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.

Lucy A Truman1, Catriona A Ford, Marta Pasikowska, John D Pound, Sarah J Wilkinson, Ingrid E Dumitriu, Lynsey Melville, Lauren A Melrose, Carol Anne Ogden, Robert Nibbs, Gerard Graham, Christophe Combadiere, Christopher D Gregory.   

Abstract

Cells undergoing apoptosis are efficiently located and engulfed by phagocytes. The mechanisms by which macrophages, the professional scavenging phagocytes of apoptotic cells, are attracted to sites of apoptosis are poorly defined. Here we show that CX3CL1/fractalkine, a chemokine and intercellular adhesion molecule, is released rapidly from apoptotic lymphocytes, via caspase- and Bcl-2-regulated mechanisms, to attract macrophages. Effective chemotaxis of macrophages to apoptotic lymphocytes is dependent on macrophage fractalkine receptor, CX3CR1. CX3CR1 deficiency caused diminished recruitment of macrophages to germinal centers of lymphoid follicles, sites of high-rate B-cell apoptosis. These results provide the first demonstration of chemokine/chemokine-receptor activity in the navigation of macrophages toward apoptotic cells and identify a mechanism by which macrophage infiltration of tissues containing apoptotic lymphocytes is achieved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799722     DOI: 10.1182/blood-2008-06-162404

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  174 in total

Review 1.  Impaired clearance of apoptotic cells in germinal centers: implications for loss of B cell tolerance and induction of autoimmunity.

Authors:  Ziaur S M Rahman
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

Review 2.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

3.  Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin.

Authors:  Irini Bournazou; John D Pound; Rodger Duffin; Stylianos Bournazos; Lynsey A Melville; Simon B Brown; Adriano G Rossi; Christopher D Gregory
Journal:  J Clin Invest       Date:  2008-12-01       Impact factor: 14.808

Review 4.  Phagocyte partnership during the onset and resolution of inflammation.

Authors:  Oliver Soehnlein; Lennart Lindbom
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 5.  Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond.

Authors:  Ruya Zhao; Rayan Kaakati; Andrew K Lee; Xinjian Liu; Fang Li; Chuan-Yuan Li
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

6.  Regulation of CX3CL1 Expression in Human First-Trimester Decidual Cells: Implications for Preeclampsia.

Authors:  S Joseph Huang; Chie-Pein Chen; Lynn Buchwalder; Ya-Chun Yu; Longzhu Piao; Chun-Yen Huang; Frederick Schatz; Charles J Lockwood
Journal:  Reprod Sci       Date:  2019-01-03       Impact factor: 3.060

7.  Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.

Authors:  Tejbeer Kaur; Kevin K Ohlemiller; Mark E Warchol
Journal:  J Comp Neurol       Date:  2017-12-17       Impact factor: 3.215

Review 8.  Osteocytes: master orchestrators of bone.

Authors:  Mitchell B Schaffler; Wing-Yee Cheung; Robert Majeska; Oran Kennedy
Journal:  Calcif Tissue Int       Date:  2013-09-17       Impact factor: 4.333

9.  Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.

Authors:  Selma Unal; Ozlem Ozdemir; Ahmet Ata Ozcimen; Yesim Oztas
Journal:  Int J Hematol       Date:  2014-12-06       Impact factor: 2.490

10.  CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.

Authors:  Shinji Shimoda; Kenichi Harada; Hiroaki Niiro; Akinobu Taketomi; Yoshihiko Maehara; Koichi Tsuneyama; Kentaro Kikuchi; Yasuni Nakanuma; Ian R Mackay; M Eric Gershwin; Koichi Akashi
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.